A. Ichikawa, H. Ono / Tetrahedron: Asymmetry 16 (2005) 2559–2568
2567
4.5. Enantioresolution of (±)-1-octen-3-ol using M9PP
acid
a silica gel cartridge (Wako Presep-C Silica Gel) and a
column chromatography (silica gel, hexane/EtOAc) giv-
ing ester (S,S)-(+)-15a (20 mg, 47%).
1
M9PP acid (S)-(+)-5 (53 mg) using DCC (112 mg),
-Octen-3-ol (±)-10 (120 lL) was similarly esterified with
4.5.5. 1-Octen-3-ol (R)-(ꢀ)-10. Ester (S,R)-(+)-15b
(85 mg) was hydrolyzed with 28% NaOMe/MeOH
(1.5 mL) giving 1-octen-3-ol (R)-(ꢀ)-10 (23 mg, 82%):
DMAP (123 mg), and CSA (26 mg) in CH Cl (0.5 mL)
2
2
yielding the first eluted ester (S,S)-(+)-15a (27 mg, 37%)
and the second eluted ester (S,R)-(+)-15b (32 mg, 43%).
2
7
½aꢁ ¼ ꢀ19 (c 0.23, EtOH), and M9PP acid (S)-(+)-5
D
(30 mg, 49%).
1
4
.5.1. 1-Octen-3-ol M9PP ester (S,S)-(+)-15a.
H
4
.5.6. Preparation of M9PP ester (S,R)-(+)-15b from
NMR (800 MHz, CDCl ): d 8.72 (1H, br d, J = 8 Hz),
3
(R)-(ꢀ)-1-octen-3-ol. 1-Octen-3-ol (R)-(ꢀ)-10 (10 mg)
was esterified with M9PP acid (S)-(+)-5 (25 mg) using
EDC (103 mg) and DMAP (127 mg) in CH Cl (0.6
2
mL). The crude product was chromatographed over
silica gel (1st CH Cl ; 2nd hexane/EtOAc) giving ester
8
.66 (1H, br d, J = 8 Hz), 8.44 (1H, dd, J = 8, 1 Hz),
7.91 (1H, br d, J = 8 Hz), 7.90 (1H, br s), 7.67 (1H,
ddd, J = 8, 7, 1 Hz), 7.63 (1H, ddd, J = 8, 7, 1 Hz),
2
7
1
4
3
.61 (1H, ddd, J = 8, 7, 1 Hz), 7.55 (1H, ddd, J = 8, 7,
Hz), 5.42 (1H, ddd, J = 17, 11, 6 Hz), 5.28 (1H, m),
.80 (1H, dt, J = 11, 1 Hz), 4.71 (1H, dt, J = 17, 1 Hz),
.16 (3H, s), 2.07 (3H, s), 1.52–1.40 (2H, m), 1.21–1.10
2
2
(
S,R)-(+)-15b (23 mg, 76%).
1
3
4
.5.7. Hydrogenation of M9PP ester (S,S)-(+)-
5a. Ester (S,S)-(+)-15a (20 mg) and 5% palladium–
(
6H, m), 0.80 (3H, t, J = 7 Hz); C NMR (201 MHz,
1
carbon (13 mg) were stirred in EtOAc (2 mL) under
CDCl ): d 173.45, 135.74, 133.76, 130.91, 130.82,
3
1
1
5
30.69, 130.08, 129.09, 127.22, 127.12, 126.85, 126.71,
26.41, 126.02, 122.94, 122.45, 116.50, 81.57, 75.72,
1.03, 33.92, 31.37, 24.59, 22.41, 21.93, 13.91; IR
H for 6 h. The suspension was filtrated, and purified
2
using HPLC (silica gel, hexane/EtOAc) giving ester
S,R)-(+)-12a (14 mg, 70%).
Acknowledgements
(
(
KBr, neat): m
2932, 2859, 1746, 1730, 1250, 1127,
max
ꢀ
50, 731 cm ; LC–MS (API-ESI, CH CN–H O 9:1):
3 2
28
1
7
4
0
+
13 ([M+Na] , 100), 359 (24), 249 (11); ½aꢁ ¼ þ32 (c
D
.49, EtOH).
The authors are indebted to Ms. Ikuko Maeda for
obtaining the NMR spectra.
1
4
.5.2. 1-Octen-3-ol M9PP ester (S,R)-(+)-15b.
H
NMR (800 MHz, CDCl ): d 8.71 (1H, br d, J = 8 Hz),
3
8
.66 (1H, br d, J = 8 Hz), 8.50 (1H, dd, J = 8, 1 Hz),
.91 (1H, br d, J = 8 Hz), 7.86 (1H, br s), 7.67 (1H,
References
7
ddd, J = 8, 7, 1 Hz), 7.63 (1H, ddd, J = 8, 7, 1 Hz),
7
1
5
3
1
2
. Mori, K. Biosci. Biotechnol. Biochem. 1996, 60, 1925–
932.
. Mori, K. J. Synth. Org. Chem. Jpn. 2004, 62, 2–13 (in
Japanese).
3. Dale, J. A.; Mosher, H. S. J. Am. Chem. Soc. 1973, 95,
512–519.
.61 (1H, ddd, J = 8, 7, 1 Hz), 7.57 (1H, ddd, J = 8, 7,
Hz), 5.64 (1H, ddd, J = 17, 11, 6 Hz), 5.23 (1H, m),
.15 (1H, dt, J = 17, 1 Hz), 5.08 (1H, dt, J = 11, 1 Hz),
.13 (3H, s), 2.07 (3H, s), 1.25–1.15 (2H, m), 0.88–0.73
1
1
3
(
4H, m), 0.61 (3H, t, J = 7 Hz), 0.58–0.46 (2H, m);
C
4
. Trost, B. M.; Belletire, J. L.; Godleski, S.; McDougal, P.
G.; Balkovec, J. M.; Baldwin, J. J.; Christy, M. E.;
Ponticello, G. S.; Varga, S. L.; Springer, J. P. J. Org.
Chem. 1986, 51, 2370–2374.
. Ohtani, I.; Kusumi, T.; Kashman, Y.; Kakisawa, H. J.
Am. Chem. Soc. 1991, 113, 4092–4096.
NMR (126 MHz, CDCl ): d 173.49, 136.13, 133.39,
3
1
1
8
1
1
30.83, 130.77, 130.72, 130.27, 129.04, 127.37, 127.25,
26.93, 126.70, 126.48, 126.06, 122.89, 122.44, 116.71,
1.35, 75.55, 50.85, 33.60, 31.11, 23.77, 22.13, 21.61,
5
3.79; IR (KBr, neat): m
132, 750, 732 cm ; LC–MS (API-ESI, CH CN–
2933, 2860, 1748, 1250,
max
ꢀ1
3
6
. Kusumi, T.; Fukushima, T.; Ohtani, I.; Kakisawa, H.
Tetrahedron Lett. 1991, 32, 2939–2942.
+
H O 9:1): 413 ([M+Na] , 100), 359 (20), 249
2
28
(
20); ½aꢁD ¼ þ34 (c 0.55, EtOH).
7. Kusumi, T.; Takahashi, H.; Xu, P.; Fukushima, T.;
Asakawa, Y.; Hashimoto, T.; Kan, Y.; Inouye, Y.
Tetrahedron Lett. 1994, 35, 4397–4400.
4
.5.3. 1-Octen-3-ol (S)-(+)-10. Ester (S,S)-(+)-15a
80 mg) was hydrolyzed with 28% NaOMe/MeOH
8
. Latypov, S. K.; Seco, J. M.; Qui n˜ o a´ , E.; Riguera, R. J.
Org. Chem. 1995, 60, 504–515.
(
(
1.5 mL) yielding 1-octen-3-ol (S)-(+)-10 (21 mg, 80%):
9
. Seco, J. M.; Qui n˜ o a´ , E.; Riguera, R. Chem. Rev. 2004, 104,
17–117.
0. Hashimoto, Y. Chem. Today (in Japanese) 1994, 283, 38–
26
½
aꢁ ¼ þ19 (c 0.21, EtOH), and M9PP acid (S)-(+)-5
D
47 mg, 82%). The chiral HPLC analysis (Chiralcel
(
OD-RH, CH CN–H O 13:7) of (S)-M9PP acid methyl
1
3
2
44.
11. Nishimura, K.; Hashimoto, Y.; Iwasaki, S. Chem. Pharm.
Bull. 1994, 42, 1157–1159.
2
3
ester (prepared using 2 M trimethylsilyldiazomethane
hexane solution) revealed that the (S)-(+)-5 recovered
was enantiopure.
1
2. Goto, J.; Hasegawa, M.; Nakamura, S.; Shimada, K.;
Nambara, T. Chem. Pharm. Bull. 1977, 25, 847–849.
3. Goto, J.; Hasegawa, M.; Nakamura, S.; Shimada, K.;
Nambara, T. J. Chromatogr. 1978, 152, 413–419.
4. Ichikawa, A. Chirality 1999, 11, 70–74.
5. Ichikawa, A.; Hiradate, S.; Sugio, A.; Kuwahara, S.;
Watanabe, M.; Harada, N. Tetrahedron: Asymmetry 1999,
10, 4075–4078.
1
4
(
.5.4. Preparation of M9PP ester (S,S)-(+)-15a from (S)-
+)-1-octen-3-ol. 1-Octen-3-ol (S)-(+)-10 (14 mg) was
1
1
esterified with M9PP acid (S)-(+)-5 (40 mg) using
DCC (104 mg), DMAP (128 mg), and CSA (38 mg) in
CH Cl (0.6 mL). The crude product was purified using
2
2